Cryo-EM reveals how the DNA replication machinery assembles at DNA damage sites

NewsGuard 100/100 Score

Cryogenic electron microscopy (cryo-EM) has enabled researchers to study how the DNA replication machinery assembles at sites where DNA is damaged.

Cellular DNA is continuously exposed to both endogenous and exogenous DNA-damaging agents, such as reactive oxygen species and UV radiation. To reduce the biological consequences of DNA damage, all living organisms have evolved mechanisms to tolerate and repair DNA damage to try to ensure that genetic information is accurately inherited. One such mechanism, called translesion synthesis (TLS), allows DNA replication to proceed through unrepaired DNA lesions.

TLS involves highly accurate DNA synthesizing enzymes (replicative DNA polymerases) being temporarily replaced with specialized, low-fidelity TLS polymerases that can ensure cell survival at the expense of introducing mutations. The mutagenic and translesion synthetic activity of TLS polymerases can result in normal cells becoming cancerous or cancer cells becoming drug resistant.

The Y-family TLS polymerase Pol K is able to perform DNA synthesis across several damaged bases and is recruited to DNA lesions by proliferating cell nuclear antigen (PCNA). Previous studies have shown that PCNA is regulated by ubiquitination.

The addition of a single ubiquitin molecule at lysine residue 164 (K164) of PCNA facilitates the recruitment and retention of TLS polymerases to damage sites, but the structural basis of the interaction between these polymerases and ubiquitinated PCNA is poorly understood."

Alfredo De Biasio, Structural Biologist, KAUST

De Biasio's group has been collaborating with the laboratory led by Samir Hamdan, an expert in single-molecule analysis of human DNA replication, since 2018. They have been using cryo-EM to investigate the three-dimensional structure and function of key protein complexes involved in DNA replication and repair.

Their latest study describes cryo-EM reconstructions of full-length human Pol K bound to DNA, an incoming nucleotide, and unmodified PCNA or mono-ubiquitylated PCNA, at near-atomic resolution. They found that in the absence of DNA, the structure of Pol K bound to PCNA is highly flexible, suggesting that binding to DNA is required to form a rigid and active complex.

Muhammad Tehseen, a senior researcher in Hamdan's group and the co-lead author of the study, has performed key functional studies elucidating how PCNA ubiquitination modulates the activity of Pol K.

"Our data provide a structural framework to explain how PCNA recruits a Y-family TLS polymerase to sites of DNA damage," Tehseen explains.

Because of the high degree of domain conservation between Y-family polymerases, some of the structural features observed in the Pol K-DNA-PCNA complex are likely to apply to other TLS polymerase complexes.

"By understanding the interactions between the proteins forming these complexes and how they are regulated, we can identify ways to reduce or increase their function for medical applications," he concludes.

Source:
Journal reference:

Lancey, C., et al. (2021) Cryo-EM structure of human Pol κ bound to DNA and mono-ubiquitylated PCNA. Nature Communications. doi.org/10.1038/s41467-021-26251-6.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baylor study reveals role of newly inherited DNA variants in recessive diseases